Simultaneous Determination of Ticagrelor and Its Metabolites in Human Plasma and Urine Using Liquid Chromatography–Tandem Mass Spectrometry

Pharmacokinetics and Pharmacodynamics of Ticagrelor and Prasugrel in Healthy Male Korean Volunteers

(2015) Hae-Sun Jeon et al.   CLINICAL THERAPEUTICS

Ticagrelor: Pharmacokinetics, Pharmacodynamics, Clinical Efficacy, and Safety

(2014) Paul P. Dobesh et al.   PHARMACOTHERAPY

Disposition and Metabolism of Ticagrelor, a Novel P2Y12 Receptor Antagonist, in Mice, Rats, and Marmosets

(2011) Y. Li et al.   DRUG METABOLISM AND DISPOSITION

Determination of unbound ticagrelor and its active metabolite (AR-C124910XX) in human plasma by equilibrium dialysis and LC–MS/MS

(2011) Henrik Sillén et al.   JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES

Absorption, Distribution, Metabolism, and Excretion of Ticagrelor in Healthy Subjects

(2010) R. Teng et al.   DRUG METABOLISM AND DISPOSITION

Pharmacokinetics, pharmacodynamics, tolerability and safety of single ascending doses of ticagrelor, a reversibly binding oral P2Y12 receptor antagonist, in healthy subjects

(2010) Renli Teng et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Determination of ticagrelor and two metabolites in plasma samples by liquid chromatography and mass spectrometry

(2010) Henrik Sillén et al.   JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES